Blenrep targets and binds to BCMA on the surface of MM cells through an anti-BCMA monoclonal antibody, which is internalized by MM cells and releases MMAF, specifically blocks cell growth via G2/M arrest and induces caspase three dependent apoptosis in MM cells. Here, TNFRSF17 is linked to Miyoshi myopathy.